Rheumatology Journals

Rheumatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Visser S et al. - Bacterial arthritis is the most dangerous form of acute monoarthritis; it can result in cartilage destruction, septicemia, and death within a few days if unrecognized. Prompt diagnosis and treatment are critical. Laboratory tests are neither sensitive nor specific in diagnosing or excluding septic arthritis. Arthrocentesis and synovial fluid analysis are mandatory for this differential. Immediately give broad-spectrum antibiotics to at-risk patients and consult an orthopedic surgeon. Mortality from septic arthritis is reported to be between 8% and 15%. Unfortunately, this has not changed dramatically despite the advent of intravenous antibiotics. The patient’s outcome depends on a host of factors, such as previous joint damage, the virulence of the infecting organism, and the speed with which adequate treatment is begun.

Related Articles

Septic arthritis of the knee joint secondary to adjacent chronic osteomyelitis of the femur in an adult
Knee Surgery, Sports Traumatology, Arthroscopy, 11/11/09    Relevance Score: 67%

Mycobacterium Kansasii Causing Septic Arthritis and Osteomyelitis in A Child
The Pediatric Infectious Disease Journal, 11/05/09    Relevance Score: 66%

Septic arthritis due to Roseomonas gilardii in an immunocompetent adolescent
Journal of Medical Microbiology, 10/21/09    Relevance Score: 64%

Extended scope of autologous chondrocyte implantation for osteochondral injuries following septic arthritis: A case report
The Knee, 10/01/09    Relevance Score: 64%

Six-year follow-up of a preformed spacer for the management of chronically infected total hip arthroplasty
Archives of Orthopaedic and Trauma Surgery, 10/23/09    Relevance Score: 63%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address